Product Description
Paclitaxel Vial Injection | Brand Name |
|
| Active Ingredient | Paclitaxel |
| Manufacturer | Abraxis Pharmaceutical |
| Form | Injection |
| Strength | 100 mg |
| Quantity | 1 bottle per pack |
(paclitaxel) is a anti cancer medicine used for the treatment of breast, lung and pancreatic cancer. It is sometimes given with other cancer medicines too.
Common Side Effects:
- hair loss
- weakness in the hands or feet
- tingling
- tiredness
- short of breath
- numbness
- rash
- changes in your liver function tests
- abnormal heart beat
- nausea and vomiting
- joint and muscle pain
- loss of body fluid (dehydration)
- swelling in the hands or feet
- low red blood cell count (anemia)
Warning:
Do not receive if:
- a women is pregnant.
- you have had a severe allergic reaction to
- your white blood cell count is below 1500 cells/mm3.
- severe liver disease.
Indications and Clinical ApplicationPaclitaxel Injection is primarily indicated for treating ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma. Its mechanism involves inhibiting cell division, thereby helping to halt cancer progression. The medication can offer significant benefit as part of a comprehensive cancer treatment plan under medical supervision.
Handling and Safety ProtocolsGiven its cytotoxic nature, Paclitaxel Injection must be handled with care. Healthcare professionals must use gloves and strict safety protocols to avoid contact with the skin or mucous membranes during preparation and administration. As a preservative-free product, proper dilution and administration are crucial to ensure patient safety and drug efficacy.
Preparation and Storage GuidelinesPaclitaxel Vial must be diluted with 0.9% Sodium Chloride Injection or 5% Dextrose Injection before intravenous administration. Store the vials at room temperature and protect them from extreme conditions. Each vial is intended for single-use, packed in an individual box, and maintains stability for up to 14 days after preparation.
FAQ's of Paclitaxel Vial injection:
Q: How should Paclitaxel Vial Injection be prepared for administration?
A: Paclitaxel Vial Injection needs to be diluted in either 0.9% Sodium Chloride Injection or 5% Dextrose Injection before intravenously infusing the medication. Preparation and administration should be performed by trained healthcare professionals in a controlled clinical setting using cytotoxic handling precautions.
Q: What cancers is Paclitaxel Vial Injection indicated to treat?
A: This medication is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma. It is commonly part of a wider chemotherapy regimen and should be used according to physician guidance.
Q: When should Paclitaxel Vial Injection not be used?
A: Paclitaxel Vial Injection is contraindicated in patients with known hypersensitivity to paclitaxel or any component of the formulation. It should not be administered in cases where severe allergic reactions are likely.
Q: Where should Paclitaxel Vial Injection be stored, and how long is it stable?
A: This product should be kept at room temperature, away from excessive heat or cold. Once prepared for infusion, its shelf life is up to 14 days, provided it is stored according to proper guidelines.
Q: What are the essential safety measures for handling Paclitaxel Vial Injection?
A: When handling Paclitaxel, always use protective gloves and avoid direct contact with your skin or mucous membranes, as the drug is cytotoxic. All preparation steps must follow institutional cytotoxic safety protocols.
Q: Why is it important to use the entire vial at once and not reuse it?
A: Paclitaxel Vial is supplied as a preservative-free solution, which means once the vial is opened and prepared for use, it should not be stored for future dosing. Single-use reduces the risk of contamination and ensures patient safety.